Please use this identifier to cite or link to this item:
https://scidar.kg.ac.rs/handle/123456789/15053
Title: | CAR T Cell Therapy for Chronic Lymphocytic Leukemia: Successes and Shortcomings |
Authors: | Todorovic Z. Jakovcev-Todorovic D. Grbovic-Markovic V. Ladjevac N. Zdravković N. Djurdjevic, Predrag Arsenijevic, Nebojsa Milovanovic, Marija Arsenijevic A. Milovanovic, Jelena |
Issue Date: | 2022 |
Abstract: | Chimeric antigen receptor T (CAR T) cell therapy achieved remarkable success in B-cell leukemia and lymphoma which led to its incorporation in treatment protocols for these diseases. CAR T cell therapy for chronic lymphocytic leukemia (CLL) patients showed less success compared to other malignant tumors. In this review, we discuss the published results regarding CAR T cell therapy of CLL, possible mechanisms of failures and expected developments. |
URI: | https://scidar.kg.ac.rs/handle/123456789/15053 |
Type: | review |
DOI: | 10.3390/curroncol29050293 |
SCOPUS: | 2-s2.0-85130550535 |
Appears in Collections: | Faculty of Medical Sciences, Kragujevac |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
PaperMissing.pdf Restricted Access | 29.85 kB | Adobe PDF | View/Open |
Items in SCIDAR are protected by copyright, with all rights reserved, unless otherwise indicated.